Directly from the USA: Alcohol Use Not Tied to Sustained Virologic Response With Hepatitis C Treatment

Alcohol use is not associated with lower odds of sustained virologic response (SVR) among patients initiating direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection, according to a study published online Sept. 26 in JAMA Network Open.

Emily J. Cartwright, M.D., from the Atlanta Veterans Affairs Medical Center, and colleagues evaluated whether alcohol use at DAA treatment initiation is associated with a decreased likelihood of SVR. The analysis included 69,229 patients with chronic HCV infection who initiated DAA therapy between Jan. 1, 2014, and June 30, 2018.

Source: Advances and More licensed by HealthDay